Profund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.98M | Sell |
10,332
-2,328
| -18% | -$1.78M | 0.29% | 51 |
|
|
2025
Q4 | $9.77M | Buy |
12,660
+825
| +7% | +$560K | 0.3% | 49 |
|
|
2025
Q3 | $6.65M | Sell |
11,835
-1,078
| -8% | -$610K | 0.22% | 75 |
|
|
2025
Q2 | $6.78M | Buy |
12,913
+1,388
| +12% | +$775K | 0.24% | 67 |
|
|
2025
Q1 | $7.31M | Sell |
11,525
-1,253
| -10% | -$862K | 0.32% | 51 |
|
|
2024
Q4 | $9.1M | Buy |
12,778
+1,075
| +9% | +$902K | 0.33% | 48 |
|
|
2024
Q3 | $12.3M | Sell |
11,703
-966
| -8% | -$1.08M | 0.47% | 34 |
|
|
2024
Q2 | $13.3M | Buy |
12,669
+1,663
| +15% | +$1.61M | 0.49% | 33 |
|
|
2024
Q1 | $10.6M | Sell |
11,006
-683
| -6% | -$649K | 0.41% | 38 |
|
|
2023
Q4 | $10.3M | Buy |
11,689
+1,523
| +15% | +$1.25M | 0.44% | 39 |
|
|
2023
Q3 | $8.37M | Buy |
10,166
+1,689
| +20% | +$1.33M | 0.46% | 35 |
|
|
2023
Q2 | $6.09M | Buy |
8,477
+691
| +9% | +$533K | 0.33% | 45 |
|
|
2023
Q1 | $6.4M | Sell |
7,786
-9,430
| -55% | -$7.11M | 0.4% | 39 |
|
|
2022
Q4 | $12.4M | Sell |
17,216
-65
| -0.4% | -$48K | 0.81% | 18 |
|
|
2022
Q3 | $11.9M | Sell |
17,281
-1,022
| -6% | -$643K | 0.86% | 21 |
|
|
2022
Q2 | $10.8M | Sell |
18,303
-2,059
| -10% | -$1.34M | 0.69% | 26 |
|
|
2022
Q1 | $14.2M | Sell |
20,362
-4,130
| -17% | -$2.61M | 0.6% | 27 |
|
|
2021
Q4 | $15.5M | Sell |
24,492
-2,742
| -10% | -$1.69M | 0.51% | 28 |
|
|
2021
Q3 | $16.5M | Buy |
27,234
+61
| +0.2% | +$37.9K | 0.56% | 26 |
|
|
2021
Q2 | $15.2M | Sell |
27,173
-932
| -3% | -$472K | 0.51% | 31 |
|
|
2021
Q1 | $13.3M | Sell |
28,105
-680
| -2% | -$331K | 0.51% | 30 |
|
|
2020
Q4 | $13.9M | Buy |
28,785
+2,332
| +9% | +$1.26M | 0.61% | 27 |
|
|
2020
Q3 | $14.8M | Sell |
26,453
-2,457
| -8% | -$1.49M | 0.76% | 22 |
|
|
2020
Q2 | $18M | Buy |
28,910
+7,356
| +34% | +$4.18M | 1% | 16 |
|
|
2020
Q1 | $10.5M | Sell |
21,554
-7,004
| -25% | -$2.89M | 0.79% | 23 |
|
|
2019
Q4 | $10.7M | Buy |
28,558
+2,917
| +11% | +$981K | 0.47% | 33 |
|
|
2019
Q3 | $7.11M | Sell |
25,641
-991
| -4% | -$293K | 0.36% | 44 |
|
|
2019
Q2 | $8.34M | Sell |
26,632
-1,695
| -6% | -$564K | 0.4% | 42 |
|
|
2019
Q1 | $11.6M | Buy |
28,327
+647
| +2% | +$266K | 0.56% | 29 |
|
|
2018
Q4 | $10.3M | Sell |
27,680
-6,593
| -19% | -$2.41M | 0.64% | 25 |
|
|
2018
Q3 | $13.8M | Buy |
34,273
+2,910
| +9% | +$1.11M | 0.53% | 26 |
|
|
2018
Q2 | $10.8M | Sell |
31,363
-1,468
| -4% | -$459K | 0.43% | 33 |
|
|
2018
Q1 | $11.3M | Sell |
32,831
-2,195
| -6% | -$763K | 0.45% | 32 |
|
|
2017
Q4 | $13.2M | Sell |
35,026
-3,506
| -9% | -$1.42M | 0.51% | 33 |
|
|
2017
Q3 | $17.2M | Buy |
38,532
+3,119
| +9% | +$1.48M | 0.72% | 21 |
|
|
2017
Q2 | $17.4M | Sell |
35,413
-1,884
| -5% | -$824K | 0.79% | 19 |
|
|
2017
Q1 | $14.5M | Sell |
37,297
-2,137
| -5% | -$792K | 0.65% | 21 |
|
|
2016
Q4 | $14.5M | Sell |
39,434
-5,394
| -12% | -$2.05M | 0.67% | 21 |
|
|
2016
Q3 | $18M | Sell |
44,828
-3,044
| -6% | -$1.22M | 0.86% | 16 |
|
|
2016
Q2 | $16.7M | Sell |
47,872
-2,457
| -5% | -$946K | 0.81% | 16 |
|
|
2016
Q1 | $18.1M | Sell |
50,329
-11,056
| -18% | -$4.56M | 0.94% | 16 |
|
|
2015
Q4 | $33.3M | Buy |
61,385
+762
| +1% | +$413K | 1.58% | 9 |
|
|
2015
Q3 | $28.2M | Sell |
60,623
-2,126
| -3% | -$1.14M | 1.61% | 8 |
|
|
2015
Q2 | $32M | Buy |
62,749
+788
| +1% | +$385K | 1.33% | 10 |
|
|
2015
Q1 | $28M | Buy |
61,961
+3,106
| +5% | +$1.32M | 1.09% | 12 |
|
|
2014
Q4 | $24.1M | Buy |
58,855
+5,538
| +10% | +$2.18M | 0.99% | 13 |
|
|
2014
Q3 | $19.2M | Sell |
53,317
-289
| -0.5% | -$96.9K | 0.9% | 14 |
|
|
2014
Q2 | $15.1M | Sell |
53,606
-11,091
| -17% | -$3.29M | 0.66% | 18 |
|
|
2014
Q1 | $19.4M | Buy |
64,697
+10,879
| +20% | +$3.35M | 0.88% | 13 |
|
|
2013
Q4 | $14.8M | Buy |
53,818
+9,844
| +22% | +$2.83M | 0.66% | 15 |
|
|
2013
Q3 | $13.8M | Buy |
43,974
+3,856
| +10% | +$1.01M | 0.73% | 13 |
|
|
2013
Q2 | $9.02M | Buy |
+40,118
| New | +$9.34M | 0.64% | 20 |
|
Other funds holding REGN
VCM
N
Profund Advisors's REGN Position: Q1 2026 in Review
Profund Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 18% in Q1 2026, selling an estimated $1.78M and leaving 10,332 shares worth $7.98M. The position accounts for 0.29% of the portfolio, ranked #51.
Profund Advisors first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.3M in Q4 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Profund Advisors held 10,332 shares of Regeneron Pharmaceuticals worth $7.98M as of Q1 2026.
- Profund Advisors sold 2,328 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.78M.
- Regeneron Pharmaceuticals made up 0.29% of Profund Advisors's portfolio in Q1 2026, its #51 holding.
- Profund Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Profund Advisors's Regeneron Pharmaceuticals position peaked at $33.3M in Q4 2015.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.